Literature DB >> 26621335

An unexpected cause for cavitary pneumonia and empyema.

Constantine Bloch-Infanger1, Katarzyna Furrer2, Mark Wiese2, Andreas Hiebinger2, Christoph M Bucher3, Sébastien Kopp4, Vladimira Hinić5, Daniel Goldenberger6.   

Abstract

Tularemia is an emerging zoonotic disease mainly of the Northern Hemisphere caused by the Gram-negative coccobacillus Francisella tularensis. It is affecting a wide range of animals and causes human disease after insect and tick bites, skin contact, ingestion and inhalation. A 66-year-old man presented to our clinic with cavitary pneumonia and distinct pleural effusion. After failure of empiric antibiotic therapy, thoracoscopic assisted decortication and partial excision of the middle lobe were conducted. Conventional culture methods and broad-range bacterial PCR including RipSeqMixed analysis were performed from the excised biopsies. Culture results remained negative but broad-range PCR targeting the first half of the 16S rRNA gene revealed F. tularensis DNA. This result was confirmed by F. tularensis-specific PCR and by serology. The source of infection could not be explored. To conclude, we report the rare clinical picture of a community-acquired pneumonia followed by pleural effusion and empyema due to F. tularensis. Broad range bacterial PCR proved to be a powerful diagnostic tool to detect the etiologic organism.

Entities:  

Keywords:  Broad-range bacterial PCR; Cavitary pneumonia; Empyema; Francisella tularensis; Tularemia

Mesh:

Year:  2015        PMID: 26621335     DOI: 10.1007/s15010-015-0861-z

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Cavitary pneumonia and skin lesions.

Authors:  Moncef Belhassen-Garcia; Virginia Velasco-Tirado; Lucia Alvela-Suárez; Maria Del Carmen Fraile-Alonso; Adela Carpio-Pérez; Javier Pardo-Lledias
Journal:  Respir Care       Date:  2011-10-12       Impact factor: 2.258

2.  Tularaemia in an emergent area in Sweden: an analysis of 234 cases in five years.

Authors:  Henrik Eliasson; Erik Bäck
Journal:  Scand J Infect Dis       Date:  2007

3.  Tularemia in Germany: the tip of the iceberg?

Authors:  W D Splettstoesser; I Piechotowski; A Buckendahl; D Frangoulidis; P Kaysser; W Kratzer; P Kimmig; E Seibold; S O Brockmann
Journal:  Epidemiol Infect       Date:  2008-09-23       Impact factor: 2.451

4.  Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia.

Authors:  A Johansson; L Berglund; U Eriksson; I Göransson; R Wollin; M Forsman; A Tärnvik; A Sjöstedt
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Clinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases.

Authors:  Ingrid B Weber; George Turabelidze; Sarah Patrick; Kevin S Griffith; Kiersten J Kugeler; Paul S Mead
Journal:  Clin Infect Dis       Date:  2012-08-21       Impact factor: 9.079

Review 6.  Streptomycin and alternative agents for the treatment of tularemia: review of the literature.

Authors:  G Enderlin; L Morales; R F Jacobs; J T Cross
Journal:  Clin Infect Dis       Date:  1994-07       Impact factor: 9.079

Review 7.  Pneumonic tularemia on Martha's Vineyard: clinical, epidemiologic, and ecological characteristics.

Authors:  Bela T Matyas; Henry S Nieder; Sam R Telford
Journal:  Ann N Y Acad Sci       Date:  2007-04-18       Impact factor: 5.691

8.  Evaluation of the novel microarray-based Prove-it™ Bone&Joint assay for direct detection of pathogens from normally sterile body sites in comparison with culture and broad-range bacterial PCR.

Authors:  Vladimira Hinić; Anne Aittakorpi; Sylvia Suter; Selda Turan; Elisabeth Schultheiss; Reno Frei; Daniel Goldenberger
Journal:  J Microbiol Methods       Date:  2014-09-04       Impact factor: 2.363

9.  Francisella tularensis subsp. tularensis induces a unique pulmonary inflammatory response: role of bacterial gene expression in temporal regulation of host defense responses.

Authors:  Kathie-Anne Walters; Rachael Olsufka; Rolf E Kuestner; Ji Hoon Cho; Hong Li; Gregory A Zornetzer; Kai Wang; Shawn J Skerrett; Adrian Ozinsky
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

  9 in total
  2 in total

1.  Neither Neoplasia Nor Tuberculosis, but Francisella.

Authors:  Adeline Mambie; Frédéric Wallet; Laurine Scherman; Sylvie Armand; Christine Vervelle; Karine Faure; Benoit Guery; Marie Titécat; Caroline Loïez
Journal:  Open Forum Infect Dis       Date:  2016-04-27       Impact factor: 3.835

2.  Tularemia presenting as suspected necrotic arachnidism.

Authors:  Heather F Sateia; Michael T Melia; Joseph Cofrancesco
Journal:  Clin Case Rep       Date:  2017-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.